Sachem Capital Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Sachem Capital Corp. on July 6, 2017, reporting events occurring on June 30, 2017. The registrant is an emerging growth company incorporated in New York, headquartered in Branford, Connecticut.
Key Financial Metrics and Debt
The filing details a material modification to the company's revolving credit facility with Bankwell Bank. Key debt metrics include:
- Credit Limit: Increased from $15 million to $20 million.
- Interest Rate: Modified to the greater of 5.5% per annum or (3-month LIBOR + 4.5%). As of July 1, 2017, the rate is 5.8%, down from 7.25%.
- Maturity Date: Extended from March 18, 2018, to June 30, 2019.
- Collateral Limit: The maximum exposure per Eligible Note Receivable increased from $450,000 to $650,000.
The filing does not provide specific values for revenue, profit, cash flow, margins, or total liquidity beyond the credit facility terms.
Material Changes
The primary material change is the expansion of the Bankwell Credit Line. The modification provides the company with an additional $5 million in available liquidity, reduces the cost of borrowing by 1.45 percentage points, and extends the repayment horizon by approximately 15 months. Additionally, the company increased the threshold for individual note receivables eligible for collateralization.
Outlook, Risks, and Management Commentary
Management commentary is limited to the description of the agreement terms. The filing indicates that the modification was entered into to improve financing terms. No specific forward-looking guidance, risk factors, or contingencies regarding future operations are disclosed in this specific report, other than the standard terms of the loan agreement.
Investor Verification Checklist
- Verify the current outstanding balance on the Bankwell Credit Line to assess immediate liquidity needs.
- Confirm the impact of the interest rate reduction on future interest expense projections.
- Review the full text of the Modification (Exhibit 10.2) for covenants or conditions not summarized in the 8-K.
- Assess the quality of the portfolio to ensure the new $650,000 per-note limit does not expose the company to excessive concentration risk.